Position in HROW
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$8,069
-$5,823 QoQ
Shares Held
190
-51.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#192
of 221 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New Hampshire holds $328,632 across 6 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
526 | $285,002 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
711 | $12,307 | |
| 3 | VTRS |
Viatris Inc
|
723 | $11,481 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
282 | $9,554 | |
| 5 | HROW |
Harrow, Inc.
This page
|
190 | $8,069 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
110 | $2,219 |
All Filings in HROW
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,069 | 190 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $13,892 | 394 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||